All In Biotech

Drug Trial Radar · NCT00640614

Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy

Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol

Last checked: Nov 19, 2026Latest source record: May 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

235

Actual

Start

Apr 2008

Primary completion

Aug 2009

Study completion Oct 2009

Sponsor

Lead sponsor
AllerdermIndustry
Sponsor type
Industry
First posted
Mar 21, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

We propose an open, prospective, multi-center Phase III study to evaluate the diagnostic performance and safety of seven new T.R.U.E. Test allergens: Gold sodium thiosulfate, Hydrocortisone-17-butyrate, Bacitracin, Parthenolide, Methyldibromoglutaronitrile, Disperse blue 106, and Bronopol.Allergen performance and safety will be evaluated in adult patients with suspected contact dermatitis, and in adult patients with a known or suspected sensitization to at least one of the seven allergens.

Conditions

  • Contact Dermatitis

Interventions

  • T.R.U.E. TEST® Skin Patch Test: Dose Response AllergensBiological

    Polyvinylpyrrolidone (PVP; excipient 1) Hydrocortisone-17-butyrate, 0.020 mg/cm2 in PVP Hydroxypropylcellulose (HPC; excipient 2) MDBGN, 0.0055 mg/cm2 in PVP Bacitracin, 0.60 mg/cm2 in HPC Gold sodium thiosulfate, 0.075 mg/cm2 in HPC Parthenolide, 0.0030 mg/cm2 in PVP Disperse Blue 106, 0.050 mg/cm2 in PVP Bronopol, 0.25 mg/cm2 in PVP Test patches, with allergens, are placed at day one and removed 48 hours later. The duration of the study lasts 21 days. However, the subject is only exposed to the study allergens for 48 hours.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diagnostic Performance: Concordance Between Investigational Allergen and Reference Allergen at Day 21Time frame: Visit 5: 21 days after patch application
  2. Diagnostic Performance: ConcordanceTime frame: Visit 5: 21 days after patch application
  3. Diagnostic Performance: ConcordanceTime frame: Visit 5: 21 days after patch application
  4. Diagnostic Performance: ConcordanceTime frame: Visit 5: 21 days after patch application
  5. Diagnostic Performance: ConcordanceTime frame: Visit 5: 21 days after patch application
  6. Diagnostic Performance: ConcordanceTime frame: Visit 5: 21 days after patch application
  7. Diagnostic Performance: ConcordanceTime frame: Visit 5: 21 days after patch application
  8. Diagnostic Performance: Sensitivity and Specificity: Gold Sodium ThiosulfateTime frame: Visit 5: 21 days after patch application
  9. Diagnostic Performance: Sensitivity and Specificity: Hydrocortisone-17-butyrateTime frame: Visit 5: 21 days after patch application
  10. Diagnostic Performance: Sensitivity and Specificity: Methyldibromo-glutaronitrileTime frame: Visit 5: 21 days after patch application
  11. Diagnostic Performance: Sensitivity and Specificity: BacitracinTime frame: Visit 5: 21 days after patch application
  12. Diagnostic Performance: Sensitivity and Specificity: ParthenolideTime frame: Visit 5: 21 days after patch application
  13. Diagnostic Performance: Sensitivity and Specificity: Disperse BlueTime frame: Visit 5: 21 days after patch application
  14. Diagnostic Performance: Sensitivity and Specificity: BronopolTime frame: Visit 5: 21 days after patch application

Locations

5 sites in 2 countries. Site status is shown where the registry gives one.

  • River City Dermatology

    Little Rock, Arkansas

  • American Dermatology Associates

    Shawnee Mission, Kansas

  • Dermatology Specialists PSC

    Louisville, Kentucky

  • Winthrop University Hospital

    Mineola, New York

  • Odense University Hospital

    Odense C, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.